ArticleBMC public health2025
Hepatitis C virus genotype 4 cluster with suspected sexual transmission in Chicago, IL.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn July 2024, the Chicago Department of Public Health (CDPH) was notified of an increasing number of genotype 4 hepatitis C virus (HCV) infections reported by Illinois Department of Public Health. CDPH initiated a cluster detection investigation. HCV genotype (GT) 4 is most commonly seen in countries in Africa and the Middle East, with limited cases in the United States.
methodsHCV GT 4 cases were reported via the Illinois National Electronic Disease Surveillance System (INEDSS). Data were matched across three surveillance systems: enhanced HIV/AIDS reporting system for HIV, Chicago Health Information Management System for syphilis, and INEDSS for Gonorrhea, Chlamydia, and mpox history in Chicago. Cases were interviewed via phone calls or field visits to the patient’s home.
resultsA total of 30 HCV GT 4 cases (23 acute and 7 chronic) were reported to the CDPH during March 6, 2023-October 21, 2024. The majority of cases had a history of sexually transmitted infection (STI) within the previous year (77%) and 63% were living with HIV. Cluster cases were male (100%), mostly non-Latino White (40%), with a median age of 37(25–66) years old. Out of 30 cases, 18 (60%) were interviewed, 3 (10%) refused, and 9(30%) were unable to locate. Of those interviewed (n = 18), 83% reported having male sex partners with a median number of 5(2-8.5) partners, and 11% reported current injection drug use (IDU).
conclusionsOverall, 11% of interviewed cases reported IDU, and no common exposure locations were identified. The high number of cases who reported having multiple sexual partners and participation in group sex which led us to conclude that sexual transmission was predominantly the suspected mode of transmission among HCV cluster cases in Chicago, IL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.